Commentary

Video

Strategies to Improve CAR T-cell Durability in Lymphoma

Samuel Yamshon, MD, of Weill Cornell Medicine/NewYork-Presbyterian, discusses strategies to improve CAR T-cell durability in patients with non-Hodgkin lymphoma.

Samuel Yamshon, MD, of Weill Cornell Medicine/NewYork-Presbyterian, discusses strategies to improve CAR T-cell durability in patients with non-Hodgkin lymphoma.

Related Videos
Alex Herrera, MD
Grzegorz S. Nowakowski, MD
Francisco Hernandez-Ilizaliturri, MD, professor, oncology, Department of Medicine—Lymphoma; director, Lymphoma Research, head, Lymphoma Translational Research Lab; associate professor, Department of Immunology, Roswell Park Comprehensive Cancer Center; clinical professor, Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Margaret E. Gatti-Mays, MD, MPH, FACP
Amitkumar Mehta, MD
Grzegorz S. Nowakowski, MD
Jasmin M. Zain, MD
Grzegorz S. Nowakowski, MD
Grzegorz S. Nowakowski, MD
Reid Merryman, MD